A Proof-of-Concept Study Evaluating LINFU™
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial uses the LINFU™ Technique, which employs ultrasound and a special dye to collect pancreatic fluid. It targets people at high risk for pancreatic cancer. The method involves stimulating the pancreas to release fluid, which is then collected and analyzed.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team for guidance.
Who Is on the Research Team?
Scott Corbett, MD, FASGE
Principal Investigator
Suncoast Endoscopy of Sarasota (a division of Florida Digestive Health Specialists)
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
LINFU™ Procedure
Participants undergo the LINFU™ Technique, which involves ultrasound excitation of the pancreas, administration of Lumason and secretin, and collection of pancreatic fluid
Follow-up
Participants are monitored for symptoms of pancreatitis and undergo blood tests to measure lipase levels
What Are the Treatments Tested in This Trial?
Interventions
- LINFU™
Find a Clinic Near You
Who Is Running the Clinical Trial?
Adenocyte, LLC
Lead Sponsor